Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript

Kote-Jarai, Zsofia, Olama, Ali Amin Al, Leongamornlert, Daniel, Tymrakiewicz, Malgorzata, Saunders, E., Guy, Michelle, Giles, Graham, Severi, Gianluca, Southey, Melissa, Hopper, John, Sit, Kei Chun, Harris, Jonathan, Batra, Jyotsna, Spurdle, Amanda, Clements, Judith, Hamdy, Freddie, Neal, David, Donovan, Jenny, Muir, Ken, Pharoah, Paul, Chanock, Stephen, Brown, N., Benlloch, Sara, Castro, E., Mahmud, N., O'Brien, L., Hall, A., Sawyer, E., Wilkinson, R., Easton, Douglas, & Eeles, Rosalind (2011) Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Human Genetics, 129(6), pp. 687-694.

View at publisher (open access)



Genome-wide association studies (GWAS) have identified more than 30 prostate cancer (PrCa) susceptibility loci. One of these (rs2735839) is located close to a plausible candidate susceptibility gene, KLK3, which encodes prostate-specific antigen (PSA). PSA is widely used as a biomarker for PrCa detection and disease monitoring. To refine the association between PrCa and variants in this region, we used genotyping data from a two-stage GWAS using samples from the UK and Australia, and the Cancer Genetic Markers of Susceptibility (CGEMS) study. Genotypes were imputed for 197 and 312 single nucleotide polymorphisms (SNPs) from HapMap2 and the 1000 Genome Project, respectively. The most significant association with PrCa was with a previously unidentified SNP, rs17632542 (combined P = 3.9 × 10−22). This association was confirmed by direct genotyping in three stages of the UK/Australian GWAS, involving 10,405 cases and 10,681 controls (combined P = 1.9 × 10−34). rs17632542 is also shown to be associated with PSA levels and it is a non-synonymous coding SNP (Ile179Thr) in KLK3. Using molecular dynamic simulation, we showed evidence that this variant has the potential to introduce alterations in the protein or affect RNA splicing. We propose that rs17632542 may directly influence PrCa risk.

Impact and interest:

46 citations in Scopus
Search Google Scholar™
46 citations in Web of Science®

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

Full-text downloads:

2 since deposited on 19 Jul 2012
2 in the past twelve months

Full-text downloads displays the total number of times this work’s files (e.g., a PDF) have been downloaded from QUT ePrints as well as the number of downloads in the previous 365 days. The count includes downloads for all files if a work has more than one.

ID Code: 52174
Item Type: Journal Article
Refereed: Yes
DOI: 10.1007/s00439-011-0981-1
ISSN: 0340-6717
Subjects: Australian and New Zealand Standard Research Classification > BIOLOGICAL SCIENCES (060000) > GENETICS (060400)
Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > COMPLEMENTARY AND ALTERNATIVE MEDICINE (110400)
Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > PAEDIATRICS AND REPRODUCTIVE MEDICINE (111400)
Divisions: Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
Copyright Owner: Springer
Deposited On: 19 Jul 2012 06:28
Last Modified: 12 May 2017 03:35

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page